Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
6
×
Tags
bristol-myers squibb
6
×
glaxosmithkline
6
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
6
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
biogen
cancer
eli lilly
fda
merck
deals
gene therapy
pfizer
roche
What
bio
roundup
cancer
days
drug
drugs
medical
news
advanced
alliance
annual
appetite
approval
arrival
ash
august
award
barcelona
biogen’s
biopharmaceutical
biotech
black
bread
bristol
busy
butter
buy
buyout
calls
cash
changing
clinical
color
companies
conference
convo
crispr
data
death
decades
Language
unset
Current search:
photo
×
" bristol-myers squibb "
×
" seattle top stories "
×
glaxosmithkline
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More